DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Foran J. et al
Maintenance decitabine improves disease-free and overall survival after intensive therapy for acute myeloid leukemia in older adults, particularly in FLT3-ITD-negative patients: ECOG-ACIN (E-A) E2906 randomized study.
ASH 2019 Abstract 115
Access:
We do not assume any responsibility for the contents of the web pages of other providers.